Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
2
×
3scan
abbvie
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
bio
bioinformatics
biontech
biotech
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breakout ventures
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical pharmacologists
clinical pharmacology
clinical research
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
data collective
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
drug discovery
dyne therapeutics
What
company’s
2
×
drug
2
×
accelerate
according
acquisitions
analysis
aren’t
automate
biggest
bio
build
buy
called
ceo
changing
daniel
debut
discovery
dyne’s
francisco
funding
gilead
involved
kitchens
labor
manual
medical
microbiome
microscope
million
moves
openly
o’day
pipeline
proprietary
raised
raises
read
research
robotic
Language
unset
Current search:
startups
×
company’s
×
drug
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@techcrunch.com
7 years ago
3Scan raises $14 million for a robotic microscope that could accelerate drug discovery